Supply of Omeprazole Extended-Release Capsules (Prescription Pharmaceutical)

The contract requires the manufacture, packaging, and delivery of Omeprazole Extended-Release Capsules in 5-bottle lots to U.S. Navy vessels under FOB Destination terms, ensuring the product meets stringent FDA current good manufacturing practices and military logistics standards. The pharmaceutical must be produced and packaged in compliance with cGMP regulations to guarantee safety, potency, and consistency, while also adhering to the unique handling and documentation requirements of military supply chains. Delivery is specifically targeted to naval vessels, necessitating precise scheduling and coordination to support operational medical needs at sea. This agreement is structured as a subcontract under the Defense Logistics Agency of the Department of Defense, classified under NAICS code 325412 for pharmaceutical and medicinal product manufacturing. The contract was posted on August 5, 2026, and is identified by the procurement reference SPE2DX25D8022 with delivery specification SPE2D926F7955. All shipments must arrive at designated naval locations under FOB Destination, meaning the supplier assumes full responsibility and risk until the product is received aboard the vessel, including final packaging, labeling, and compliance with military-specific packaging and traceability protocols.